Sinopharm Group Co. Ltd.
http://ir.sinopharmgroup.com.cn/html/index.php
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sinopharm Group Co. Ltd.
CanSino's Inhaled COVID Vaccine Shows Early Promise As Potential Booster
Early study results show CanSino’s inhaled vaccine for COVID-19 triggered an immune response similar to its injected counterpart.
Massive Selloff Hits US, HK-Listed China Health Cos, Clouds Sunny Prospects
Both Nasdaq- and Hong Kong-listed shares in Chinese health-related companies have been free falling with heavy volumes, after foreign investors spooked by China's general crackdown on the tech sector rushed to exit. The two-day sell-off shows high uncertainty and investors' anxiety over the regulatory overreach but underlying fundamentals still seem strong.
Low Sinopharm Protection In Elderly Casts New Doubt On Chinese COVID-19 Vaccines
A new study in over 400 people reignites fears about the apparent low efficacy of Chinese COVID-19 vaccines, especially among the elderly, and adding to the debate around the need for booster shots.
Will Health Insurance In India Pinch Your Pocket Post COVID-19?
While a Star Health study found high hospitalization costs for COVID-19 patients in India, those vaccinated paid 24% less and faced 81% lower mortality risk. However, insurers are unlikely to offer lower premiums to those vaccinated, even as the prospects for an overall hike remain uncertain, say experts.
Company Information
- Industry
- Distributors
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Vaccines
- Other Names / Subsidiaries
-
- China National Medical Device Co., Ltd. (CMIC)
- China National Pharmaceutical Industry Co., Ltd. (Sinopharm CNPIC)
- China National Scientific Instruments & Materials Corporation (Sinopharm CSIMC)
- China Sinopharm International Corporation (Sinopharm International)
- Sinopharm A-THINK Pharmaceutical Co., Ltd
- Sinopharm Group Company Limited